Mortality risk associated with psychological distress and major depression: A population-based cohort study

2018 ◽  
Vol 234 ◽  
pp. 117-123 ◽  
Author(s):  
Maria Chiu ◽  
Simone Vigod ◽  
Farah Rahman ◽  
Andrew S. Wilton ◽  
Michael Lebenbaum ◽  
...  
Keyword(s):  
Cohort Study ◽  
Psychological Distress ◽  
Major Depression ◽  
Mortality Risk ◽  
Population Based

scholarly journals The direct healthcare costs associated with psychological distress and major depression: A population-based cohort study in Ontario, Canada

PLoS ONE ◽  
2017 ◽  
Vol 12 (9) ◽  
pp. e0184268 ◽  
Author(s):  
Maria Chiu ◽  
Michael Lebenbaum ◽  
Joyce Cheng ◽  
Claire de Oliveira ◽  
Paul Kurdyak
Keyword(s):  
Cohort Study ◽  
Psychological Distress ◽  
Major Depression ◽  
Healthcare Costs ◽  
Population Based ◽  
Direct Healthcare Costs

scholarly journals The Risk of Mortality among Psoriatic Patients with Varying Severity: A Nationwide Population-Based Cohort Study in Taiwan

2018 ◽  
Vol 15 (12) ◽  
pp. 2622 ◽  
Author(s):  
Ying-Xiu Dai ◽  
Ming-Chun Hsu ◽  
Hsiao-Yun Hu ◽  
Yun-Ting Chang ◽  
Tzeng-Ji Chen ◽  
...  
Keyword(s):  
Cohort Study ◽  
Psoriatic Arthritis ◽  
Mortality Risk ◽  
Psoriasis Patient ◽  
Population Based ◽  
Cox Proportional Hazards ◽  
Severe Psoriasis ◽  
Control Group ◽  
Research Database ◽  
Control Subjects

Background: Previous studies showed conflicting results regarding the mortality risk in psoriasis patients with respect to disease severity and presence of psoriatic arthritis. This study aimed to determine the mortality risk in patients with mild and severe psoriasis and patients with psoriatic arthritis (PsA). Methods: A nationwide population-based cohort study was conducted based on data from the Taiwan National Health Insurance Research Database between 2002 and 2012. Incident psoriasis subjects were classified into two groups: psoriasis without arthritis and psoriasis with arthritis. Patients who had received systemic therapy and/or phototherapy were classified as having severe psoriasis; otherwise, patients were classified as having mild psoriasis. Control subjects without psoriasis were selected to match each psoriasis patient from the database within the same observational period. Cox proportional hazards analysis was used to compare the hazard ratio (HR) of time to death. Results: A total of 106,701 patients with psoriasis were included in this study. After controlling for demographics and comorbidities, psoriasis patients had a higher mortality risk compared with the control group (HR 1.41; 95% confidence interval (CI) 1.36 to 1.46). Compared with psoriasis alone, the mortality risk was not increased for PsA (HR = 1.01; 95% CI 0.93 to 1.10). Besides, severe psoriasis did not increase mortality risk compared with mild psoriasis (HR = 1.0; 95% CI 0.95 to 1.06). Conclusions: Patients with psoriasis had a higher mortality risk compared with control subjects, whereas psoriasis severity and presence of PsA had no impact on mortality risk in psoriasis patients.

S1908 Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study

2008 ◽  
Vol 134 (4) ◽  
pp. A-781-A-782 ◽  
Author(s):  
Winston Dunn ◽  
Ronghui Xu ◽  
Deborah L. Wingard ◽  
Christopher Rogers ◽  
Paul Angulo ◽  
...  
Keyword(s):  
Cohort Study ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Mortality Risk ◽  
Fatty Liver Disease ◽  
Population Based ◽  
Nonalcoholic Fatty Liver

scholarly journals Recipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study

PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0152324 ◽  
Author(s):  
Hsiu-Pin Chen ◽  
Yung-Fong Tsai ◽  
Jr-Rung Lin ◽  
Fu-Chao Liu ◽  
Huang-Ping Yu
Keyword(s):  
Liver Transplantation ◽  
Cohort Study ◽  
Mortality Risk ◽  
Population Based ◽  
Recipient Age

scholarly journals Association of chronic kidney disease with mortality risk in patients with lung cancer: a nationwide Taiwan population-based cohort study

BMJ Open ◽  
2018 ◽  
Vol 8 (1) ◽  
pp. e019661 ◽  
Author(s):  
Yu-Feng Wei ◽  
Jung-Yueh Chen ◽  
Ho-Shen Lee ◽  
Jiun-Ting Wu ◽  
Chi-Kuei Hsu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Chronic Kidney Disease ◽  
Cohort Study ◽  
Kidney Disease ◽  
Renal Disease ◽  
Mortality Risk ◽  
Population Based ◽  
Research Database ◽  
Cox Regression Analysis ◽  
Increased Risk

ObjectiveOur population-based research aimed to clarify the association between chronic kidney disease (CKD) and mortality risk in patients with lung cancer.DesignRetrospective cohort studySettingNational health insurance research database in TaiwanParticipantsAll (n=1 37 077) Taiwanese residents who were diagnosed with lung cancer between 1997 and 2012 were identified. Eligible patients with baseline CKD (n=2269) were matched with controls (1:4, n=9076) without renal disease according to age, sex and the index day of lung cancer diagnosis.MethodsThe cumulative incidence of death was calculated by the Kaplan-Meier method, and the risk determinants were explored by the Cox proportional hazards model.ResultsMortality occurred in 1866 (82.24%) and 7135 (78.61%) patients with and without CKD, respectively (P=0.0001). The cumulative incidences of mortality in patients with and without chronic renal disease were 72.8% vs 61.6% at 1 year, 82.0% vs 76.6% at 2 years and 88.9% vs 87.2% at 5 years, respectively. After adjusting for multiple confounding factors including age and comorbidities, Cox regression analysis revealed that CKD was associated with an increased risk of mortality (adjusted HR 1.38; 95% CI 1.29 to 1.47). Stratified analysis further showed that the association was consistent across patient subgroups.ConclusionComorbidity associated with CKD is a risk factor for mortality in patients with lung cancer.

scholarly journals Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study

2008 ◽  
Vol 103 (9) ◽  
pp. 2263-2271 ◽  
Author(s):  
Winston Dunn ◽  
Ronghui Xu ◽  
Deborah L. Wingard ◽  
Christopher Rogers ◽  
Paul Angulo ◽  
...  
Keyword(s):  
Cohort Study ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Mortality Risk ◽  
Fatty Liver Disease ◽  
Population Based ◽  
Nonalcoholic Fatty Liver
Sign in / Sign up

Export Citation Format

Share Document